Shukra Pharmaceuticals fundamental analysis

31.46

2.86 (10.00%)
Last updated on 5 Jun, 2026 | 15:59 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Shukra Pharmaceuticals Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Shukra Pharmaceuticals reflects: Price – Expensive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost
Invest Now